1. Home
  2. RVMD vs OSK Comparison

RVMD vs OSK Comparison

Compare RVMD & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • OSK
  • Stock Information
  • Founded
  • RVMD 2014
  • OSK 1917
  • Country
  • RVMD United States
  • OSK United States
  • Employees
  • RVMD N/A
  • OSK N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • OSK Auto Manufacturing
  • Sector
  • RVMD Health Care
  • OSK Consumer Discretionary
  • Exchange
  • RVMD Nasdaq
  • OSK Nasdaq
  • Market Cap
  • RVMD 7.7B
  • OSK 6.6B
  • IPO Year
  • RVMD 2020
  • OSK N/A
  • Fundamental
  • Price
  • RVMD $41.84
  • OSK $97.20
  • Analyst Decision
  • RVMD Strong Buy
  • OSK Buy
  • Analyst Count
  • RVMD 13
  • OSK 18
  • Target Price
  • RVMD $49.54
  • OSK $126.94
  • AVG Volume (30 Days)
  • RVMD 787.2K
  • OSK 376.6K
  • Earning Date
  • RVMD 11-04-2024
  • OSK 10-24-2024
  • Dividend Yield
  • RVMD N/A
  • OSK 1.89%
  • EPS Growth
  • RVMD N/A
  • OSK 67.63
  • EPS
  • RVMD N/A
  • OSK 10.34
  • Revenue
  • RVMD $742,000.00
  • OSK $10,367,400,000.00
  • Revenue This Year
  • RVMD N/A
  • OSK $11.49
  • Revenue Next Year
  • RVMD $100.00
  • OSK N/A
  • P/E Ratio
  • RVMD N/A
  • OSK $9.40
  • Revenue Growth
  • RVMD N/A
  • OSK 15.82
  • 52 Week Low
  • RVMD $15.44
  • OSK $86.10
  • 52 Week High
  • RVMD $48.61
  • OSK $127.98
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 44.72
  • OSK 35.24
  • Support Level
  • RVMD $41.09
  • OSK $105.05
  • Resistance Level
  • RVMD $43.39
  • OSK $108.10
  • Average True Range (ATR)
  • RVMD 1.59
  • OSK 2.60
  • MACD
  • RVMD -0.15
  • OSK -0.57
  • Stochastic Oscillator
  • RVMD 20.59
  • OSK 3.91

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About OSK Oshkosh Corporation (Holding Company)Common Stock

Oshkosh is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms, a global leader. The company had manufactured joint light tactical vehicles for the us Department of Defense. However, Oshkosh recently lost the JLTV recompete, bringing into focus its us Postal Service contract, which calls for the electrification of us postal vehicles. The company reports in three segments—access equipment (52% of revenue), defense (22%), and vocational (27%)—and generated $9.6 billion in revenue in 2023.

Share on Social Networks: